RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
RT @Ped_Neph: 🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for comple…
🆓 Don't forget - FREE ACCESS REVIEW for 1 month 🆓 Pathogenesis and treatment of ANCA-associated vasculitis—a role for complement https://t.co/6meqwhseDw @IPNA_PedNeph @SickKidsNews @sickkids @UofT https://t.co/QeaYcxQw6O
RT @SwastiThinks: Good update on ANCA-associated vasculitis https://t.co/0gLVYhJ1JY
Reminder folks. Making articles free to access for a limited period is NOT #openaccess https://t.co/NiQyGSUttB
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @SwastiThinks: Good update on ANCA-associated vasculitis https://t.co/0gLVYhJ1JY
RT @SwastiThinks: Good update on ANCA-associated vasculitis https://t.co/0gLVYhJ1JY
RT @SwastiThinks: Good update on ANCA-associated vasculitis https://t.co/0gLVYhJ1JY
RT @SwastiThinks: Good update on ANCA-associated vasculitis https://t.co/0gLVYhJ1JY
Good update on ANCA-associated vasculitis https://t.co/0gLVYhJ1JY
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
RT @LangoteAmit: Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45Zkbmt…
Key Clinical trials in ANCA assoc Vasculitis #FOAMED #Nephpearls #openaccess https://t.co/QJPS1Rph0C https://t.co/t45ZkbmtAI
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @Ped_Neph: Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculit…
RT @McDawg: When items are "open access" for a limited period, that's not really #openaccess is it ! e.g. https://t.co/NiQyGSUttB
RT @McDawg: When items are "open access" for a limited period, that's not really #openaccess is it ! e.g. https://t.co/NiQyGSUttB
When items are "open access" for a limited period, that's not really #openaccess is it ! e.g. https://t.co/NiQyGSUttB
Don't forget - this Review is FREE #openaccess until 31st December 🆓 'Pathogenesis and treatment of ANCA-associated vasculitis—a role for complement' Damien Noone, Diane Hebert, Christoph Licht #springerlink https://t.co/UQTw6XePG2 https://t.co/JdejVptS
RT @Ped_Neph: NEW review: Pathogenesis & treatment of ANCA-assoc vasculitis— role for complement #springerlink @SickKidsNews @UofT https://…
Pathogenesis and treatment of ANCA-associated vasculitis—a role for complement https://t.co/7Mo4KH4Sb0 @Ped_Neph
NEW review: Pathogenesis & treatment of ANCA-assoc vasculitis— role for complement #springerlink @SickKidsNews @UofT https://t.co/UQTw6XePG2